UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 141

Sortiert nach

Symptoms of Autonomic Dysfunction in Systemic Sclerosis Assessed by the COMPASS-31 Questionnaire

Journal of rheumatology, 2018-08, Vol.45 (8), p.1145

2018

Volltextzugriff (PDF)

Gastrointestinal involvement in systemic sclerosis: diagnosis and management

Current opinion in rheumatology, 2018-11, Vol.30 (6), p.533-540

2018

Volltextzugriff (PDF)

Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension

Circulation (New York, N.Y.), 2016-06, Vol.133 (24), p.2413-2422

2016

Volltextzugriff (PDF)

Brief Report: Anti–RNPC‐3 Antibodies As a Marker of Cancer‐Associated Scleroderma

Arthritis & rheumatology (Hoboken, N.J.), 2017-06, Vol.69 (6), p.1306-1312

2017

Volltextzugriff (PDF)

Cancer in Systemic Sclerosis: Analysis of Antibodies Against Components of the Th/To Complex

Arthritis & rheumatology (Hoboken, N.J.), 2021-02, Vol.73 (2), p.315-323

2021

Volltextzugriff (PDF)

Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis

Arthritis research & therapy, 2022-01, Vol.24 (1), p.19-19, Article 19

2022

Volltextzugriff (PDF)

Clinical Trials in Systemic Sclerosis: Crossroads and Opportunities

Arthritis & rheumatology (Hoboken, N.J.), 2023-08, Vol.75 (8), p.1328-1330

Hummers, Laura K.

2023

Volltextzugriff (PDF)

Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension

Circulation. Heart failure, 2013-09, Vol.6 (5), p.953-963

2013

Volltextzugriff (PDF)

Hemodynamic Predictors of Survival in Scleroderma-related Pulmonary Arterial Hypertension

American journal of respiratory and critical care medicine, 2010-07, Vol.182 (2), p.252-260

2010

Volltextzugriff (PDF)

Association of Fibrosing Myopathy in Systemic Sclerosis and Higher Mortality

Arthritis care & research (2010), 2017-11, Vol.69 (11), p.1764-1770

2017

Volltextzugriff (PDF)

Predicting clinical events using Bayesian multivariate linear mixed models with application to scleroderma

BMC medical research methodology, 2021-11, Vol.21 (1), p.1-249, Article 249

2021

Volltextzugriff (PDF)

Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension

Journal of rheumatology, 2010-01, Vol.37 (1), p.98

2010

Volltextzugriff (PDF)

Evaluation of risk factors for pseudo-obstruction in systemic sclerosis

Seminars in arthritis and rheumatism, 2019-12, Vol.49 (3), p.405-410

2019

Volltextzugriff (PDF)

Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma

Nature communications, 2019-03, Vol.10 (1), p.1128-1128, Article 1128

2019

Volltextzugriff (PDF)

Abnormalities in the regulators of angiogenesis in patients with scleroderma

Journal of rheumatology, 2009-03, Vol.36 (3), p.576

2009

Volltextzugriff (PDF)

Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis

Annals of the rheumatic diseases, 2011-06, Vol.70 (6), p.1104-1107

2011

Volltextzugriff (PDF)

Scleroderma-like Fibrosing Disorders

Rheumatic diseases clinics of North America, 2008-02, Vol.34 (1), p.199-220

2008

Volltextzugriff (PDF)

Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated pulmonary arterial hypertension

Journal of rheumatology, 2011-11, Vol.38 (11), p.2410

2011

Volltextzugriff (PDF)

Late-age onset systemic sclerosis

Journal of rheumatology, 2011-07, Vol.38 (7), p.1317

2011

Volltextzugriff (PDF)

Thrombotic complications after radial arterial line placement in systemic sclerosis: A case series

Seminars in arthritis and rheumatism, 2016-10, Vol.46 (2), p.196-199

2016

Volltextzugriff (PDF)

Symptomatic and Electrodiagnostic Features of Peripheral Neuropathy in Scleroderma

Arthritis care & research (2010), 2016-08, Vol.68 (8), p.1150-1157

2016

Volltextzugriff (PDF)

Oxalate nephropathy in systemic sclerosis: Case series and review of the literature

Seminars in arthritis and rheumatism, 2015-12, Vol.45 (3), p.315-320

2015

Volltextzugriff (PDF)

Severity of systemic sclerosis-associated pulmonary arterial hypertension in African Americans

Medicine (Baltimore), 2014-07, Vol.93 (5), p.177-185

2014

Volltextzugriff (PDF)

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(130)
Mit Volltextzugriff
(121)

Publikationsform

Sprache

Englisch
(141)
Japanisch
(28)

Erscheinungsjahr

n.n

Thema

Science & Technology
(106)
Life Sciences & Biomedicine
(105)
Humans
(85)
Rheumatology
(85)
Female
(61)
Male
(56)
Middle Aged
(55)
Scleroderma
(53)
Adult
(46)
Systemic Sclerosis
(45)
Scleroderma, Systemic - Complications
(43)
Aged
(38)
Biological And Medical Sciences
(18)
Medical Sciences
(18)
Pulmonary Hypertension
(18)
Risk Factors
(18)
Hypertension, Pulmonary - Etiology
(17)
Patients
(17)
Scleroderma, Systemic - Diagnosis
(17)
Severity Of Illness Index
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Symptoms of Autonomic Dysfunction in Systemic Sclerosis Assessed by the COMPASS-31 Questionnaire

Gastrointestinal involvement in systemic sclerosis: diagnosis and management

Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension

Brief Report: Anti–RNPC‐3 Antibodies As a Marker of Cancer‐Associated Scleroderma

Cancer in Systemic Sclerosis: Analysis of Antibodies Against Components of the Th/To Complex

Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis

Survival and Predictors of Mortality in Systemic Sclerosis‐Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry

Clinical Trials in Systemic Sclerosis: Crossroads and Opportunities

Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension

Hemodynamic Predictors of Survival in Scleroderma-related Pulmonary Arterial Hypertension

Association of Fibrosing Myopathy in Systemic Sclerosis and Higher Mortality

Predicting clinical events using Bayesian multivariate linear mixed models with application to scleroderma

Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension

Evaluation of risk factors for pseudo-obstruction in systemic sclerosis

Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma

Abnormalities in the regulators of angiogenesis in patients with scleroderma

Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis

Scleroderma-like Fibrosing Disorders

Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated pulmonary arterial hypertension

Late-age onset systemic sclerosis

Thrombotic complications after radial arterial line placement in systemic sclerosis: A case series

Symptomatic and Electrodiagnostic Features of Peripheral Neuropathy in Scleroderma

Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study

Oxalate nephropathy in systemic sclerosis: Case series and review of the literature

Severity of systemic sclerosis-associated pulmonary arterial hypertension in African Americans

Suchergebnisse filtern